Skip to content

13F-HR filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-14, with 54 holding rows worth $168,447,000.

Accession
0001618205-21-000002
Filed
2021-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 54 entries on the cover page, a total value of $168,447,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $168,447,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM794,186$50,137,000thousands by filing date
BIODESIX INC09075X108COM1,104,953$22,442,000thousands by filing date
Accelerate Diagnostics00430H102COM2,213,326$18,386,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM80,200$7,799,000thousands by filing date
QUIDEL CORP74838J101COM58,644$7,502,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM177,000$4,567,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK314,143$4,140,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK111,000$3,913,000thousands by filing date
BIOGEN INC COM09062X103Stock12,100$3,385,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock18,000$3,011,000thousands by filing date
ACCELERON PHARMA INC00434H108COM18,672$2,532,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM60,114$2,505,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM230,000$2,420,000thousands by filing date
BLUEBIRD BIO INC09609G100COM75,500$2,276,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW300,000$1,863,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM92,000$1,840,000thousands by filing date
MASIMO CORP COM574795100Stock8,000$1,837,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK190,000$1,539,000thousands by filing date
CHEMOCENTRYX INC16383L106COM30,000$1,537,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW22,000$1,527,000thousands by filing date
BIORA THERAPEUTICS INC74319F107COM270,000$1,285,000thousands by filing date
HARROW INC415858109COM180,000$1,215,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM80,000$1,202,000thousands by filing date
CORCEPT THERAPEUTICS INC218352102COM50,000$1,190,000thousands by filing date
SOLENO THERAPEUTICS INC834203101COM876,899$1,105,000thousands by filing date
ANGION BIOMEDICA CORP03476J107COM60,615$1,095,000thousands by filing date
EQUITRANS MIDSTREAM CORP NPV294600101COM133,050$1,086,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM40,000$1,028,000thousands by filing date
CONTINENTAL RES INC212015101COM38,600$999,000thousands by filing date
ARVINAS INC04335A105COM15,000$992,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM40,000$962,000thousands by filing date
CONTRAFECT CORP212326102COM200,000$960,000thousands by filing date
OVINTIV INC69047Q102COM34,350$818,000thousands by filing date
INARI MED INC45332Y109COM7,000$749,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock15,000$723,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM103,104$696,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM10,000$684,000thousands by filing date
PROGYNY INC COM74340E103Stock15,000$668,000thousands by filing date
ALKERMES PLCG01767105SHS35,000$654,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM3,800$604,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM15,000$583,000thousands by filing date
XENCOR INC98401F105COMMON STOCK12,300$530,000thousands by filing date
LAIRD SUPERFOOD INC50736T102CMN14,000$525,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock30,000$495,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM38,000$375,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM8,000$343,000thousands by filing date
Inflarx NvN44821101COM70,000$273,000thousands by filing date
ARCUTIS BIOTHERAPEUTICS INC03969K108COM9,000$260,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM10,000$259,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM10,000$256,000thousands by filing date
YIELD10 BIOSCIENCE INC98585K102COM18,952$238,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock20,000$203,000thousands by filing date
THERAPEUTICSMD INC88338N107COM100,000$134,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM20,000$100,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-21-000002this filing2021-05-14acceptance time not in the bulk data set